Canaccord Genuity Downgrades Staar Surgical to Hold, Lowers Price Target to $48
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst William Plovanic has downgraded Staar Surgical (NASDAQ:STAA) from Buy to Hold and lowered the price target from $77 to $48.
August 04, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Staar Surgical's rating has been downgraded from Buy to Hold by Canaccord Genuity, and its price target has been lowered from $77 to $48.
The downgrade from Buy to Hold indicates a less optimistic outlook for the company's stock, which could lead to a decrease in demand and potentially a lower stock price. The lowering of the price target also suggests that the analyst believes the stock is currently overvalued, which could further pressure the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100